May 14 (Reuters)-
Kohjin Bio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 5.21 4.77 5.68
(+9.1 pct) (+0.6 pct) (+9.1 pct)
Operating 991 mln 596 mln 1.07
(+66.1 pct) (-52.9 pct) (+7.5 pct)
Recurring 1.07 635 mln 1.14
(+67.6 pct) (-48.9 pct) (+6.6 pct)
Net
Net 794 mln 384 mln 822 mln
(+106.4 pct) (-53.6 pct) (+3.5 pct)
EPS 157.57 yen 92.43 yen 160.85 yen
Ann Div 24.00 yen 14.00 yen 25.00 yen
-Q2 Div NIL NIL
-Q4 Div 24.00 yen 14.00 yen 25.00 yen
NOTE - Kohjin Bio Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=177A.T